BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32776513)

  • 1. RT-PCR analysis of mRNA revealed the splice-altering effect of rare intronic variants in monogenic disorders.
    Zhang X; Qiu W; Liu H; Ye X; Sun Y; Fan Y; Yu Y
    Ann Hum Genet; 2020 Nov; 84(6):456-462. PubMed ID: 32776513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of splicing assays to detect an intronic variant of the OCRL gene in Lowe syndrome.
    Nakanishi K; Nozu K; Hiramoto R; Minamikawa S; Yamamura T; Fujimura J; Horinouchi T; Ninchoji T; Kaito H; Morisada N; Ishimori S; Nakanishi K; Morioka I; Awano H; Matsuo M; Iijima K
    Eur J Med Genet; 2017 Dec; 60(12):631-634. PubMed ID: 28803024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of aberrant GAA pre-mRNA splicing in pompe disease using a generic approach.
    Bergsma AJ; Kroos M; Hoogeveen-Westerveld M; Halley D; van der Ploeg AT; Pijnappel WW
    Hum Mutat; 2015 Jan; 36(1):57-68. PubMed ID: 25243733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and functional characterization of a hemizygous novel intronic variant in OCRL gene causes Lowe syndrome.
    Sun J; Zhou Z; Weng C; Wang C; Chen J; Feng X; Yu P; Qi M
    Clin Exp Nephrol; 2020 Aug; 24(8):657-665. PubMed ID: 32394213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incomplete cryptic splicing by an intronic mutation of OCRL in patients with partial phenotypes of Lowe syndrome.
    Nakano E; Yoshida A; Miyama Y; Yabuuchi T; Kajiho Y; Kanda S; Miura K; Oka A; Harita Y
    J Hum Genet; 2020 Oct; 65(10):831-839. PubMed ID: 32427950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the functional impact on the pre-mRNA splicing process of 28 nucleotide variants associated with Pompe disease in GAA exon 2 and their recovery using antisense technology.
    Goina E; Musco L; Dardis A; Buratti E
    Hum Mutat; 2019 Nov; 40(11):2121-2130. PubMed ID: 31301153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico prioritization and further functional characterization of SPINK1 intronic variants.
    Zou WB; Wu H; Boulling A; Cooper DN; Li ZS; Liao Z; Chen JM; Férec C
    Hum Genomics; 2017 May; 11(1):7. PubMed ID: 28472998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A generic assay for the identification of splicing variants that induce nonsense-mediated decay in Pompe disease.
    Bergsma AJ; In 't Groen SLM; Catalano F; Yamanaka M; Takahashi S; Okumiya T; van der Ploeg AT; Pijnappel WWMP
    Eur J Hum Genet; 2021 Mar; 29(3):422-433. PubMed ID: 33168984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene.
    Bonnet C; Krieger S; Vezain M; Rousselin A; Tournier I; Martins A; Berthet P; Chevrier A; Dugast C; Layet V; Rossi A; Lidereau R; Frébourg T; Hardouin A; Tosi M
    J Med Genet; 2008 Jul; 45(7):438-46. PubMed ID: 18424508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal splicing of hepatocyte nuclear factor 1 alpha in maturity-onset diabetes of the young.
    Bulman MP; Harries LW; Hansen T; Shepherd M; Kelly WF; Hattersley AT; Ellard S
    Diabetologia; 2002 Oct; 45(10):1463-7. PubMed ID: 12378390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two intronic variants of CYP11B1 and CYP17A1 disrupt mRNA splicing and cause congenital adrenal hyperplasia (CAH).
    Dai W; Zhang X; Liu H; Sun Y; Fan Y; Yu Y
    J Pediatr Endocrinol Metab; 2020 Sep; 33(9):1225-1229. PubMed ID: 32687482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation detection in glycogen storage-disease type II by RT-PCR and automated sequencing.
    Hermans MM; van Leenen D; Kroos MA; Reuser AJ
    Biochem Biophys Res Commun; 1997 Dec; 241(2):414-8. PubMed ID: 9425285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erosive vitreoretinopathy and wagner disease are caused by intronic mutations in CSPG2/Versican that result in an imbalance of splice variants.
    Mukhopadhyay A; Nikopoulos K; Maugeri A; de Brouwer AP; van Nouhuys CE; Boon CJ; Perveen R; Zegers HA; Wittebol-Post D; van den Biesen PR; van der Velde-Visser SD; Brunner HG; Black GC; Hoyng CB; Cremers FP
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3565-72. PubMed ID: 16877430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant splicing in MLH1 and MSH2 due to exonic and intronic variants.
    Pagenstecher C; Wehner M; Friedl W; Rahner N; Aretz S; Friedrichs N; Sengteller M; Henn W; Buettner R; Propping P; Mangold E
    Hum Genet; 2006 Mar; 119(1-2):9-22. PubMed ID: 16341550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Christianson syndrome: A novel splicing variant of SLC9A6 causes exon skipping in a Chinese boy and a literature review.
    Zhang X; Wu X; Liu H; Song T; Jiang Y; He H; Yang S; Xie Y
    J Clin Lab Anal; 2022 Jan; 36(1):e24123. PubMed ID: 34791706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of a novel splicing mutation (IVS2-2A-->C) of SEDL gene on RNA processing].
    Luo Q; Gao C; Wang HL; Zhou JH; Gao TZ
    Yi Chuan; 2005 Jul; 27(4):544-8. PubMed ID: 16120574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Characterization and Rescue of a Deep Intronic Mutation in OCRL Gene Responsible for Lowe Syndrome.
    Rendu J; Montjean R; Coutton C; Suri M; Chicanne G; Petiot A; Brocard J; Grunwald D; Pietri Rouxel F; Payrastre B; Lunardi J; Dorseuil O; Marty I; Fauré J
    Hum Mutat; 2017 Feb; 38(2):152-159. PubMed ID: 27790796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18.
    Fraile-Bethencourt E; Díez-Gómez B; Velásquez-Zapata V; Acedo A; Sanz DJ; Velasco EA
    PLoS Genet; 2017 Mar; 13(3):e1006691. PubMed ID: 28339459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A non-invasive diagnostic assay for rapid detection and characterization of aberrant mRNA-splicing by nonsense mediated decay inhibition.
    Häuser F; Gökce S; Werner G; Danckwardt S; Sollfrank S; Neukirch C; Beyer V; Hennermann JB; Lackner KJ; Mengel E; Rossmann H
    Mol Genet Metab; 2020 May; 130(1):27-35. PubMed ID: 32222271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new family with an SLC9A6 mutation expanding the phenotypic spectrum of Christianson syndrome.
    Masurel-Paulet A; Piton A; Chancenotte S; Redin C; Thauvin-Robinet C; Henrenger Y; Minot D; Creppy A; Ruffier-Bourdet M; Thevenon J; Kuentz P; Lehalle D; Curie A; Blanchard G; Ghosn E; Bonnet M; Archimbaud-Devilliers M; Huet F; Perret O; Philip N; Mandel JL; Faivre L
    Am J Med Genet A; 2016 Aug; 170(8):2103-10. PubMed ID: 27256868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.